Some Psoriasis Biologics Better Than Others for Preventing Progression to PsA

[ad_1]

(MedPage Today) — Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or IL-23 inhibitors compared with those receiving tumor necrosis factor (TNF) inhibitors, a single-center study…

[ad_2]

Source link : https://www.medpagetoday.com/dermatology/psoriasis/114256

Author :

Publish date : 2025-02-18 19:02:40

Copyright for syndicated content belongs to the linked Source.